Beijing Tong Ren Tang Chinese Medicine Company Limited

HK$5.78As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3613Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (2.65%)
Div yield 6.41%
ROE 8.80%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.39
PE TTM 13.41
TSR TTM (29.06%)
Mkt cap HK$4.834B
ROIC 16.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.42
28.52%
(79.49%)
Buy 7|7|8|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.09
0.10
38.62%
28.01%
35.82%
28.91%
Revenue$M
267.6
279.8
285.8
288.3
6.32%
5.12%
3.43%
6.58%
Peers (US$616.6M)
Cap (US$)
PE
853.5M
8.360x
719.3M
6.072x
612.0M
10.54x
Capital
TTM
5Y
10Y
Leveragex
5.925
0.960
0.961
EBIT/Intx
3.504
0.269
0.229
Own earn%
(77.06)
52.28
63.04
Sh yield%
30.68
47.05
51.05
Owners
Insiders/Inst%
3.86
52.12
Short interest%
4.01
SBC / revenue%
0.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
9–16
$1 testx
—
Incr. ROIC%
5